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Abstract 
We have shown that continuous maternal exposure to the complex mixture of environmental 
chemicals (ECs) found in human biosolids (sewage sludge), disrupts mRNA expression of 
genes crucial for development and long-term regulation of hypothalamo-pituitary gonadal 
(HPG) function in sheep. This study investigated whether exposure to ECs only during 
preconceptional period or only during pregnancy perturbed key regulatory genes within the 
hypothalamus and pituitary gland and whether these effects were different from chronic (life-
long) exposure to biosolid ECs. The findings demonstrate that the timing and duration of 
maternal EC exposure influences the subsequent effects on the fetal neuroendocrine system 
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in a sex-specific manner. Maternal exposure prior to conception or during pregnancy only, 
altered the expression of key fetal neuroendocrine regulatory systems such as GnRH and 
kisspeptin to a greater extent than when maternal exposure was ‘life-long’. Furthermore, 
hypothalamic gene expression was affected to a greater extent in males than in females, 
and following EC exposure, male fetuses expressed more “female-like” mRNA levels for 
some key neuroendocrine genes. This is the first study to show that “real-life” maternal 
exposure to low levels of a complex cocktail of chemicals prior to conception can 
subsequently affect the developing fetal neuroendocrine system. These findings 
demonstrate that the developing neuroendocrine system is sensitive to EC mixtures in a sex-
dimorphic manner likely to predispose to reproductive dysfunction in later life. 
 
Introduction 
It is evident from human and animal studies that many factors, including maternal nutrition 
and stress during pregnancy, can alter normal fetal development and programme risk of 
disease in later life (1, 2). The Developmental Origins of Health and Disease (DOHaD) 
paradigm is one of the most rapidly expanding areas of biomedical research during the last 
decade (3). Maternal pregnancy exposure to exogenous chemicals/drugs either voluntarily, 
e.g. cigarette smoking and alcohol consumption (4-7), or unintentionally, e.g. ubiquitous 
environmental chemicals (ECs), is associated with altered fetal development leading to 
reproductive dysfunction in both males and females (8-10). Indeed, EC exposure is a 
candidate contributory factor to recently observed changes in human reproductive health, 
including increased incidence of cryptorchidism and hypospadias (11-13) and reduced 
semen quality (14-16) in males. In females, the same link has been made to precocious 
puberty (17, 18), early menopause (19) and breast cancer (20, 21). Many ECs are classified 
as endocrine disrupting chemicals (EDCs), because they can enter the body and disrupt 
normal endogenous hormone release/action via a range of mechanisms. Some ECs can be 
stored in fat but are mobilised during periods of increased metabolism, such as during 
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pregnancy. However, the potential impact of maternal chemical exposure prior to conception 
on subsequent fetal development has not been extensively studied.  
 
When considering the factors that might influence the effects of ECs on fetal development, it 
is important to remember that humans are rarely exposed to high levels of individual 
chemicals, but rather to mixtures of different chemicals. Such ECs are at low individual 
concentrations and potentially can have synergistic or additive effects (22) while also varying 
in concentration across gestation. Therefore, the physiological responses associated with 
exposure can differ according to the sensitivity of the fetus at the time of exposure, i.e. which 
critical developmental windows are affected (23). Exposure to various exogenous or/and 
endogenous changes during specific windows of developmental programming may affect the 
long-term health of the offspring with a disparity between males and females in the timing of 
onset and severity of disease outcomes, often with a long latency  (24, 25). 
 
To address the importance of pregnancy exposure relative to life-long exposure to 
environmentally-relevant, low levels of chemical mixtures, the current study builds on 
previously published work that used an ovine model of EC exposure, via grazing on pasture 
treated with human biosolids (sewage sludge). Biosolids, a by-product of waste water 
treatment, contains a complex mixture of chemicals and pollutants with known endocrine 
disrupting capabilities (26). This complex mixture represents chemicals from anthropogenic 
sources and is thus reflective of everyday human chemical exposure from multiple sources. 
We have previously shown that life-long maternal exposure to biosolids is associated with 
behavioural changes (27) and reduced bone density (28) in adult offspring; altered fetal 
testis and ovary development (23, 29, 30) and altered mRNA expression of regulatory 
systems within the fetal reproductive neuroendocrine axis (31, 32), while more recent studies 
have reported that the timing of maternal exposure has significant effects on fetal ovarian 
development (23, 33). 
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Reproductive success depends upon activity within the hypothalamic gonadotrophin-
releasing hormone (GnRH) neurosecretory system which is dynamically regulated and highly 
sensitive to the organisational and activational effects of endogenous steroids (34, 35). The 
GnRH regulatory centres are, therefore, significant targets through which ECs may act to 
perturb reproductive function (36, 37).  We have previously shown that life-long maternal 
exposure to biosolids treated pastures results in altered expression of hypothalamic mRNA 
for GnRH as well as afferent regulators of GnRH including galanin. More importantly, 
kisspeptin, the product of the KISS1 gene and proposed gatekeeper of puberty, which plays 
a critical role in the steroidogenic regulation of GnRH (38) is also affected (31). The aim of 
the present study was to determine how the timing of maternal EC exposure, relative to 
pregnancy, impacts on the expression of GnRH, oestrogen receptor alpha (ERα), KISS1 and 
KISS1R within the fetal reproductive neuroendocrine system. 
 
Materials and Methods 
Ethics Statement  
All animals used in this study were treated humanely with due consideration to the alleviation 
of pain, suffering, distress or lasting harm according to the James Hutton Institute's Local 
Ethical Committee and fully licensed by the United Kingdom's Animals (Scientific Procedures) 
Act 1986 under Project License authority (60/3356). All in-vivo components of the study and 
euthanasia of animals were conducted at the James Hutton Institute under this legal 
framework operating at the highest ethical standards. 
 
Experimental animals, management and monitoring  
The experimental design has been described previously (33, 39). Briefly, four experimental 
groups of ewes were set up in parallel: two groups of ewes (n=12 / group) were exposed to 
either the biosolids treated (TT) or control (CC) pastures throughout their lives up to the time 
of mating and thereafter until the time of slaughter at 110 days gestation. In a crossover 
design, an additional group of ewes which had been raised on control pastures were 
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transferred to the biosolids-treated pastures 4 days prior to mating and maintained on these 
treated pastures until slaughter at 110 days gestation (CT, n=11) and a group of ewes that 
had been maintained on biosolids-treated pastures throughout their lives were, 14 days prior 
to  introduction of the rams (washout period to prevent faecal EC contamination of control 
pasture), transferred and subsequently maintained on control pastures (TC, n=10) (See 
supplementary Fig. S1) as described earlier (33, 39). 
 
Tissue Collection 
Prior to slaughter at 110 days of gestation, ewe body weight and condition was determined 
and a terminal blood sample taken.  Ewes were euthanised by barbiturate overdose and 
fetuses were then removed, weighed and blood samples collected. Only one fetus per ewe 
was used for this study to control for maternal or sibling influences. Maternal and fetal blood 
samples were centrifuged immediately and plasma stored at -20°C for hormone 
measurements. Hypothalami and pituitary glands were collected from fetal animals from 
each of the 4 maternal exposure groups, halved, frozen on dry ice and then stored at -80°C 
until mRNA extraction and analysis. While still frozen, fetal hypothalamic blocks were cut into 
coronal slices (~2mm) as previously described (35). The most rostral slice was cut ~1mm in 
front of the optic chiasm and encompassed the preoptic area (POA). A slice was also 
harvested ~1mm dorsal to the mediobasal hypothalamus/median eminence which 
encompassed the arcuate nucleus (ARC). From each of these tissue slices, approximately 
20-30mg of tissue was harvested, using a tissue punch, for RNA extraction from an area 
close to the ventricle that would encompass each of these two nuclei. Approximately 20-
30mg of tissue was also harvested from the mid sagittal face of the fetal pituitary gland for 
RNA extraction (40).  
 
RNA extraction 
Total RNA was extracted from hypothalamic and pituitary gland  tissue using TRIzol® 
(Invitrogen, UK) as recommended by the manufacturers, and mRNA (200-300ng) was 
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reverse transcribed using Moloney-Murine Leukemia virus (M-MLV) reverse transcriptase 
(Invitrogen, UK), random hexamers (Promega UK) and Rnasin (Promega, UK) as described 
previously (41). Purity and quantity of mRNA and cDNA were assessed using an ND-1000 
spectrophotometer (NanoDrop® Technologies).  
 
Hormone Measurements 
Maternal and fetal plasma concentrations of oestradiol, testosterone, progesterone FSH, LH 
and inhibin A were estimated, in duplicate, as described in (33) using protocols previously 
validated in sheep. For oestradiol, mean intra- and inter-assay coefficients of variation (CV) 
were 8.5% and 6.15% respectively, and assay sensitivity averaged 0.27 pg/ml. The mean 
intra-assay CV was 7.5% and assay sensitivities were 0.1 and 0.2 ng/ml for FSH and LH, 
respectively and assay sensitivity averaged 0.19 ng/tube. For plasma testosterone, mean 
intra- and inter-assay CV were 9.4 % and 9.6 % respectively over three assays and assay 
sensitivity averaged 0.015 ng/ml. Progesterone mean intra- and inter-assay CV were 1.9% 
and 3.2% respectively and assay sensitivity 0.67 nmol/l.  
Quantitative PCR (qPCR) 
mRNA expression in the hypothalamus and pituitary gland was quantified using SYBR green 
quantitative real time PCR, in a 96-well plate format using a Stratagene MX3000 cycler. 
Reactions contained 5 μl 2 × SYBRII mastermix (Stratagene, Amsterdam, Netherlands), 
primer (100 nm), and template in a total volume of 10 μl. At the end of the amplification 
phase, a melting curve analysis was carried out on the products formed. mRNA expression 
of genes of interest were quantified using the comparative CT (cycle threshold) method (42) 
and gene expression calculated relative to the reference gene (β-actin). Primers for all 
genes were designed using Primer Express 2.0, to span intron/exon boundaries and to have 
an annealing temperature of 65°C.   
Statistical Analysis 
All data are presented as mean ± S.E.M. Expression data was analysed using a generalised 
linear model (GLM) where within each hypothalamic region, the dependent variables were 
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sex and treatment. Graphics were produced using R Studio version 2.15.0 (R Development 
Core Team, 2013) with the additional packages sciplot and PMCMR (43, 44). All explanatory 
variables were analysed for covariance and variance inflation and none were found. Fetus 
number per ewe was included as an explanatory variable and had no significant effect on the 
results, P<0.05 was considered statistically significant. 
 
Results 
Maternal morphology and endocrinology  
Data on maternal and female fetal morphology and endocrinology at day 110 of gestation 
have been previously published as part of a related study (33) and are shown in 
supplementary Figure S2. Of relevance to the present study, maternal body condition scores 
were indicative of a normal nutritional state for the stage of gestation in all groups and there 
were no differences in the number or the sex ratio of fetuses produced between the 4 
different exposure groups.  
 
Fetal morphology and endocrinology.  
As reported previously for females (33) and summarised in Table 1 (to allow comparison of 
sex differences), there was no significant effects of either treatment or sex on fetal gross 
morphology.  
 
Timing of maternal exposure  and effects on fetal HPG axis 
GnRH and GnRHR expression 
Hypothalamic GnRH mRNA expression levels in control (CC) males were not statistically 
different from females in the POA, although in the ARC, GnRH mRNA expression was 
significantly (P<0.05) higher in males compared to females (Figure 1A). Biosolids exposure 
had significant effects on GnRH mRNA expression in both the POA and ARC, the effects 
differed between the two nuclei and did not follow the same trend in males and females.  
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In the hypothalamus in female fetuses, the effects of exposure to biosolid EDs were 
observed only in the POA. The pregnancy exposure alone group (CT) and life-long exposure 
(TT) groups had significantly (P<0.05) higher expression of GnRH mRNA compared to the 
CC group (Figure 1A).In the ARC, there was no effect of treatment on GnRH expression in 
female fetuses. .  
In males, effects were observed in both hypothalamic regions. GnRH mRNA expression in 
the POA was significantly (P<0.05) reduced in the TT relative to the CC group While in the 
ARC, GnRH mRNA expression in male fetuses was significantly (P<0.05) lower in all 
biosolid exposed (CT, TC, TT) groups relative to the CC group.  In the ARC, where, in which 
males from the CC group had significantly (P<0.05) higher GnRH expression than females, 
this sex difference was reversed in the preconception only exposure (TC) and TT groups, 
such that GnRH mRNA expression was significantly (P<0.05) lower in males compared to 
females (Figure 1B).  
In the pituitary gland there were no significant sex differences in GnRHR expression in any 
of the treatment groups (Figure 1C). In female fetuses GnRHR mRNA expression was 
significantly (P<0.05) lower in the CT and TT groups relative to the CC group (Figure 1C). In 
male fetuses the only significant difference in GnRHR mRNA expression was seen in the CT 
group, in which expression was significantly (P<0.05) lower than the CC group, as was 
found in females (Figure 1C).  
 
KISS1 and KISSR 
There was no sex difference in hypothalamic KISS1 mRNA expression in the POA or ARC 
(Figure 2A and 2B) within the control group.  
In the POA, in the females, there were no significant effects of biosolids exposure on KISS1 
mRNA expression (Figure 2A). In contrast, in the POA of male fetuses, KISS1 mRNA 
expression was significantly (P<0.05) increased in the TC and CT compared to the CC 
group (Figure 2A) but was significantly (P<0.05) reduced in the TT group compared to the 
CC group (Figure 2A).  
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In the ARC, there was no effect of biosolids exposure on KISS1 expression in female fetuses, 
however, in the males, KISS1 mRNA expression was significantly (P<0.05) higher in the CT 
group and significantly (P<0.05) lower in the TT group, relative to the CC group (Figure 2B).  
For hypothalamic KISS1R mRNA expression, there were no sex differences in mRNA 
expression in the CC groups in either the POA or the ARC (Figure 2C and 2D). In the POA, 
in female fetuses there was no significant effect of biosolids exposure on KISSR mRNA 
expression levels. In male fetuses, however, KISSR mRNA expression in the POA, was 
significantly (P<0.05) lower in the TT group relative to CC group (Figure 2C). In the ARC, 
there were no statistically significant effects on KISSR expression in either males or females. 
In both the POA and the ARC in the TT group, females expressed significantly higher levels 
of KISSR compared to males (Figure 2A).  
 
Gonadotrophins 
As reported previously and summarised in Table 1 there was no effect of treatment on 
plasma LH concentrations in the female fetuses. In males, however, LH was significantly 
higher in the CT and TC groups compared to CC group. When comparing LH concentrations 
between males and females, there was no significant difference in the CC and TT groups but 
both CT and TC males had significantly higher LH concentrations compared to females of 
the same treatment groups. In the females, the FSH concentration in the TT group was 
significantly higher than the CT group, which had the lowest FSH concentration of all groups, 
but was not different to the CC or TC groups. In male fetuses, FSH concentrations were 
significantly lower than the females in all of the treatment groups but FSH concentrations did 
not differ between treatment groups. 
 
Gonadal hormones 
As expected, in all groups, male fetuses had significantly (P<0.05) higher testosterone 
concentrations compared to females. However, plasma testosterone concentrations in both 
female and male fetuses were not significantly different between treatment groups In female 
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fetuses, the oestradiol concentration was significantly (P<0.05) higher in the CT group than 
the CC and TT groups... Plasma Inhibin A concentrations in females were significantly 
(P<0.05) higher in the TT group than both CC and CT but not the TC group. In male fetuses, 
Inhibin A concentrations were not significantly affected by treatment but were significantly 
(P<0.05) higher than the females in all exposure groups. 
 
Timing of maternal exposure and effects on fetal oestrogen and arylhydrocarbon receptor 
mRNA expression 
In both the POA and ARC regions of the hypothalamus, control males had significantly 
(P<0.05) higher ERα mRNA expression compared to control females (Figure 3A and 3B). 
Effects of exposure to biosolids on fetal ERα mRNA expression were again different 
between the POA and ARC regions and did not follow the same trend in males and females.  
In the POA in males there was no significant effect of exposure to biosolids on ERα mRNA 
expression (Figure 3A), whereas in female fetuses, the TT group had significantly (P<0.05) 
higher expression of ERα mRNA in the POA relative to the CC group (Figure 3A). In the TT 
group, there was also no significant sex difference in ERα mRNA expression, which 
contrasts with the CC, CT and TC groups in which significantly (P<0.05) higher ERα mRNA 
expression was seen in males compared to females for both POA and ARC.  
In the ARC, biosolids exposure did not affect ERα mRNA expression in females, but in the 
males, ERα mRNA expression was significantly (P<0.05) lower in the TC and TT groups 
relative to the CC group (Figure 3B). In the TT group, as in the POA, this meant that the 
significantly (P<0.05) higher ERα mRNA expression seen in the ARC in CC males compared 
to females was no longer evident (Figure 3B). 
In the pituitary gland, a significant sex difference was seen in ERα mRNA expression in the 
CC group, levels being significantly lower (P<0.05) in males compared to females (Figure 
3C), however, this difference was not evident in any of the biosolids exposed groups, and in 
fact ERα mRNA expression was significantly (P<0.05) lower in female fetuses from the CT, 
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TC and TT groups compared to the CC group (Figure 3C). There was no significant 
difference in ERα mRNA expression in the ARC between any of the male exposure groups.  
 
For AhR, in both hypothalamic regions, CC males had significantly (P<0.05) higher AhR 
expression compared to females (Figure 4A and 4B).  
In the POA, there was no effect of biosolids exposure on AhR mRNA expression in either 
sex (Figure 4A). In the ARC, in the females, there was a similar absence of effect of 
biosolids exposure on AhR mRNA expression, whereas in males AhR mRNA expression 
was significantly (P<0.05) increased in the CT relative to the CC group, although this was 
not evident in the TC and TT groups, relative to the controls  (Figure 4B). There was a 
significant sex difference in pituitary gland AhR expression in the CC group, with expression 
notably higher in female fetuses had significantly (P<0.05). However, this difference was not 
evident in any of the biosolids exposed groups (Figure 4C). In female fetuses, AhR mRNA 
expression was significantly lower in the TC, CT and TT groups compared to the CC group. 
There was no effect of biosolids exposure on AhR mRNA expression in male fetal pituitary 
glands (Figure 4C). 
 
Discussion 
This is the first study to address the effects of the timing of maternal exposure to 
environmentally relevant chemical mixtures on the fetal reproductive neuroendocrine system. 
The findings from this ovine model are significant for the following reasons. They show that: 
1) the effects of maternal exposure to mixtures of ECs in biosolids on the fetal 
neuroendocrine system, are sexually dimorphic 2) the timing and duration of maternal EC 
exposure is critical in determining its effects on the fetal neuroendocrine system; in particular 
EC exposure prior to conception, but then not during pregnancy, can affect development of 
the fetal reproductive neuroendocrine system. 3)the effect of maternal exposure to EC 
mixtures during pregnancy alone on the fetal neuroendocrine system can be different 
compared to those seen when maternal exposure has been life-long i.e. prior to and during 
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pregnancy; 4) life-long maternal exposure to chemical mixtures does not necessarily mean 
greater/more effects on gene expression in the fetal neuroendocrine system; . 
 
Specifically, there the inhibitory effects of EC exposure on GnRH and KISS1 (POA and ARC) 
and ERα (ARC) and KISSR (POA) mRNA expression in the male hypothalamus are more 
pronounced and indeed were in the opposite direction relative to the obersved increase in 
GnRH and ERα mRNA expression within the female were not suppressed, but were 
increased in the POA. The suppression of KISS1 expression in fetal males is consistent with 
our previous studies and studies in rodents exposed to endocrine disruptors during fetal 
development (48, 49) and highlights that the kisspeptin system is a potential target for 
endocrine disruption. While our results in females are in contrast to those in males, they are 
consistent with previous studies in rodents prenatally exposed. The most striking similarity 
was an increase in GnRH mRNA expression that has been observed in the POA in response 
to in-utero exposure to chemical  mixtures (PCBs) in Aroclor 1221, methoxyclor and 
chloropyrifos (50), and increased ERα mRNA expression was observed following exposure 
to bisphenol A in female rodents (51) and sheep (52). However, these findings contrast with 
those of Mahoney and Padmanabhan (2010), who showed a consistent suppression of 
GnRH expression in the POA following prenatal exposure to BPA and methoxyclor in both 
male and female sheep. Because biosolids represent largely unquantifiable low-level mixed 
exposure, it is difficult to draw direct comparisons to the effects on the fetal hypothalamus of 
other “known dose” exposure studies on exposures in different species. Furthermore, it was 
shown that there is a cocktail effect between the different molecules from a mixture that does 
not boil down to the sum of the effects but may be responsible for divergent/inverse effects 
of single molecules. Nevertheless, the observation that GnRH expression is altered by life-
long low-level maternal EC exposure in the current study is important, since increased 
GnRH expression may be a contributory factor in precocious puberty in females (45), and 
therefore may have implications for later adult reproductive function.  
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For some of the hypothalamic genes investigated in the present study (GnRH (POA), KISS1 
and KISSR), mRNA expression showed sex-specific disturbances after life-long EC 
exposure. However, for others, the sexually differentiated pattern seen in controls, was 
reversed (GnRH, ARC) or lost (ERα) in the fetuses of ewes that had been exposed to ECs 
throughout their lifetime. These effects on sexually differentiated gene expression were not 
seen in our previous study which used the same life-long EC exposure paradigm. While this 
could be due to lower numbers of animals in our previous study, we cannot rule out the 
possibility that animals in the two studies were exposed to different chemical concentrations 
or chemical mixtures due to variation in biosolids composition or grazing patterns.  
 
The sexually dimorphic effects of EC exposure were not limited to the hypothalamus, as life-
long EC exposure also significantly affected mRNA expression in the pituitary gland. 
However, in this tissue, the effects were more pronounced in females, in which expression of 
all investigated genes (GnRHR, ERα, AhR) was significantly reduced, compared to males in 
which GnRHR mRNA expression was reduced only in the pregnancy exposed group (CT). 
The results for GnRHR and ERα in the female pituitary gland are consistent with our 
previous studies in fetuses from life-long biosolids exposed mothers (31, 32). 
These results provide compelling evidence that the fetal neuroendocrine system is altered 
following life-long maternal exposure to EC mixtures in biosolids and critically, that the 
reproductive neuroendocrine axis of male and female fetuses may react differently to EC 
exposure. Sexually dimorphic differences in the brain are present in fetal life, and are found 
in nearly every region of the brain, particularly the hypothalamus (53, 54). It is, therefore, not 
surprising that the effects of life-long chemical exposure on expression levels of key 
reproductive neuroendocrine systems are sexually dimorphic. Numerous studies in rodents 
have demonstrated sex-specific endocrine disrupting effects on brain development as well 
as differential effects on different brain regions as also shown in this study (55). In particular, 
studies on rodents exposed during gestation, to the PCB mixture Aroclor 1221, showed 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
altered expression of numerous oestrogen-sensitive genes in the anteroventral 
periventricular nucleus (AVPV) in females but not in males (48); in contrast, the ARC was 
affected in males but not females. Although there are critical species differences to be taken 
into account, it is well established that sexual differentiation of the hypothalamus is an 
oestrogen dependent process (41). During the developmentally critical sensitive period, 
oestrogen induces a permanent alteration in neural control of physiological functions which 
persist into adulthood (56, 57). Accumulating evidence suggests an important role for 
oestrogen and kisspeptin receptors in the hypothalamus for sexual differentiation of the brain 
and behaviour (58). Many of the chemicals found in biosolids have been shown to have 
oestrogenic effects and the present study provides evidence that oestrogen sensitive genes 
in the hypothalamus and pituitary gland may be a target for EDCs, which could potentially 
have long term effects on neuroendocrine function.  
 
The current study specifically addressed the question as to whether the timing of maternal 
exposure is critical for determining subsequent effects of EC exposure on the fetal 
neuroendocrine axis. In the groups in which maternal exposure was during pregnancy alone, 
significant sexually differentiated, region-specific, effects on the expression of key 
neuroendocrine genes were observed also. However, the total number of changes in mRNA 
expression (relative to controls) was less in the pregnancy alone exposure group compared 
to the continuous maternal exposure group, as might be expected, given that exposure was 
shorter. The differential effects between the pregnancy exposure alone and life-long 
exposure groups, could be related to adaptive responses such as increases in xenobiotic 
metabolizing enzyme (DME) expression or activity (e.g. (59)) which may have been induced 
by the preconception exposure and then maintained during pregnancy, thereby mitigating 
the effects of biosolids exposure on the fetus. 
 
When maternal EC exposure occured only prior to pregnancy, this also resulted in lower 
expression of mRNA for GnRH and ERα in the ARC (males only). Similarly, for the pituitary 
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gland, preconception biosolids exposure significantly reduced ERα and AhR expression to 
the same extent as did life-long exposure in females. However, the exposure effects on 
other genes were different, for example POA KISS1 mRNA expression in males was 
increased after preconception exposure, whereas life-long exposure reduced KISS1 mRNA 
expression.These results are consistent with our previous findings of effects in the ovaries of 
fetuses from mothers exposed to biosolids only prior to conception (33). This result is of 
specific concern since fetal EC exposure in this paradigm is likely to be mostly attributable to 
mobilisation of chemicals from maternal fat stores. Worryingly, these would have been laid 
down prior to mating, then released later in pregnancy when energy demands in the mother 
are increased. As might be expected, the overall number of effects of exposure were fewer 
in the fetuses born to mothers exposed to ECs prior to pregnancy, and the pattern of 
changes observed, differed from that seen in the life-long maternal exposure group. This is 
likely to reflect the fact that the fetus may be exposed to varying levels and mixtures of ECs 
as they are released from adipose stores throughout several important windows of 
development. This is important since it has recently been shown that there is differential 
temporal sensitivity across gestation where maternal exposure to biosolids during different 
gestational windows has varying effects on the fetal ovary (23) which is difficult to predict or 
measure.   
 
Another explanation is that the oocyte/embryo product during the pre-and peri-conceptional 
period was affected by EDC exposure. Profound epigenetic modifications to the genome 
occur in the late folliculogenesis and in early embryo as a normal part of development. 
Recent evidence suggests that environmental signals that act during early development may 
also result in epigenetic changes which may play a role in mediating the association 
between early life exposures and later phenotype (60, 61). Most evidence of 
periconceptional ‘programming’ has emerged from maternal nutritional models but also other 
in vivo and in vitro conditions including assisted reproductive treatments, show consistent 
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outcomes (62). To rule in the hypothesis of a release of stored EDCs by the mother or 
epigenetic alteration of the oocyte/zygote, crossed embryo transfer would be necessary.  
 
The mechanisms by which chemicals in biosolids may affect neuroendocrine function are 
likely to be numerous given the mixture of different chemicals present in biosolids and the 
importance of the timing of exposure. Determining the potential mechanisms underlying 
neuroendocrine disruption are therefore difficult, although given the similar effects of 
exposure on both ERα and AhR, the current study would suggest that activation of both of 
these receptors may be involved. Several chemicals found in biosolids, such as PCB 
congeners, are well known ligands for the AhR, which is involved in the detoxification of 
endogenous and exogenous substrates by cytochrome P450 enzymes and cell regulation, 
oxidative stress and apoptosis (63). Several previous studies have demonstrated that AhR is 
expressed in the hypothalamus and pituitary gland and activated by endocrine disruptors in 
these tissues (64-66). In addition, AhR expression in the hypothalamus is sexually dimorphic 
during late gestation in rodents (66), with males expressing higher levels of AhR compared 
to females, which is in agreement with the results of the current study.  Moreover, in the 
current study, pregnancy exposure to biosolids also increased AhR expression in males but 
not females which is also in accordance with previous studies of mixed prenatal PCB 
exposure in rats (66). The similar effects of biosolids exposure on AhR and ERα are perhaps 
not surprising since activation of the AhR pathway can interfere with ERα pathways through 
a number of mechanisms. There are complex interactions between AhR, ERα and 
gonadotrophin release and synthesis by direct actions on gonadotrophs (65). Induction of 
ERα and AhR may represent putative pathways through which biosolids exposure may alter 
neuroendocrine hormone release. 
 
A critical question is whether alterations to the expression of genes involved in regulation of 
gonadotrophin release are adaptive, or may impact on normal reproductive function in later 
life. In the current study, gonadotrophin concentrations were quantified in the EC exposed 
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fetuses and while it is recognised that fetal gonadotrophin secretion may not mirror what 
would be seen in the adult, it was interesting to note that gonadotrophin concentrations were 
significantly affected by EC exposure however the current study measured plasma 
concentrations at a single time point, and it is unclear how this concentration corresponds to 
the pulsatility of LH secretion, which is likely to be different in each animal. In addition, we 
have previously shown in adult males exposed to biosolids in-utero, that significantly altered 
testis structure, is not reflected ingonadrotrophin or steroid hormone concentrations which 
were unaffected. While the present study cannot confirm whether altered neuroendocrine 
gene expression in response to biosolids exposure is related to changes in gonadotrophin 
release, our previous study would suggest that altered fetal reproductive neuroendocrine 
development may have long term consequences for reproductive function, at least in males 
however this warrants further investigation. 
 
The results of the present study support and extend our previous neuroendocrine findings 
(31), but crucially, highlight that fetal sex as well as the timing of maternal exposure are 
critical when assessing the effects of exposure to low levels of mixtures of chemicals.  
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Table 1 
  
Treatment groups Constant exposure profile Cross-over exposure profile
S
E
X
 
CC  
(n=12) 
   
TT 
(n=12) 
 
 
CT 
(n=11) 
 
 
TC 
(n=10) 
Morphology 
     
Body weight (g)              F 
M
1845±50      
1979±119 
1829±84    
1966±54 
 1922±84       
1801±107 
1827±73      
1911±64 
Endocrinology 
     
LH (ng/ml)                      F 
M
1.65±0.33     
2.5±0.5a 
1.79±0.37   
1.9±0.3 
 1.73±0.75      
2.8±0.6 b 
2.49±0.92    
3.4±0.8 b 
FSH (ng/ml)                   F 
M
1.28±0.08   
0.72±0.05 
1.52±0.11a   
0.73±0.06 
 1.18±0.13b    
0.79±0.1 
1.37±0.16   
0.59±0.07 
Testosterone  (ng/ml)    F 
M
0.11±0.01   
0.29±0.05 
0.11±0.01   
0.34±0.03 
 0.12±0.01     
0.34±0.06 
0.12±0.01   
0.36±0.05 
Oestradiol (pg/ml)          F 
M
5.7±2.4a      
19.1±3.7a 
1.5±0.9b   
33.9±4.6b 
 7.6±4.4a          
12.2±1.9a 
4.0±1.5        
16.8±3.2a 
Inhibin A (pg/ml)             F 
M
7.69±0.69a    
173±6 
12.99±1.89b 
168±7 
 8.69±1.69a     
152±10 
9.95±1.60     
159±6 
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